Mother-child dyads living with HIV in the Western Cape, South Africa: Undetectable = Undetectable?

IF 4.6 1区 医学 Q2 IMMUNOLOGY
Kim Anderson, Helena Rabie, Brian S. Eley, Lisa Frigati, James Nuttall, Emma Kalk, Alexa Heekes, Gayathri Sridhar, Leigh Ragone, Vani Vannappagari, Vanessa Mudaly, Andrew Boulle, Mary-Ann Davies
{"title":"Mother-child dyads living with HIV in the Western Cape, South Africa: Undetectable = Undetectable?","authors":"Kim Anderson,&nbsp;Helena Rabie,&nbsp;Brian S. Eley,&nbsp;Lisa Frigati,&nbsp;James Nuttall,&nbsp;Emma Kalk,&nbsp;Alexa Heekes,&nbsp;Gayathri Sridhar,&nbsp;Leigh Ragone,&nbsp;Vani Vannappagari,&nbsp;Vanessa Mudaly,&nbsp;Andrew Boulle,&nbsp;Mary-Ann Davies","doi":"10.1002/jia2.26418","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Globally, children living with HIV continue to lag behind UNAIDS targets for viral suppression (VS). Because studies with linked mother-child data are limited, we describe VS and associated factors among young children in a setting with early infant HIV testing (at birth, age 10 weeks and 6 months) and early protease inhibitor-based first-line antiretroviral therapy (ART).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We analysed routinely collected mother-child data for children living with HIV born 2018–2022 in Western Cape province, South Africa (followed through mid-2023). We assessed associations between child and maternal viral load (VL) results at 12 and 24 months after child ART start using logistic regression, adjusted for child sex, birthyear, severity of child immunodeficiency at ART start, maternal age and timing of maternal HIV diagnosis.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 2219 children living with HIV; 30% were diagnosed at birth (≤7 days), 41% before age 1 year (8−365 days) and 29% at age &gt;1 year. Overall, 5% (<i>n</i> = 112/2219) of children died, a third of whom had not started ART; 90% of children (<i>n</i> = 1990) started ART, at median age 5 months (IQR 1–16). Median follow-up from ART start was 26 months (IQR 14–40). Among children with available VL at 12 months (<i>n</i> = 853/1582), 24 months (<i>n</i> = 614/1129) and 36 months (<i>n</i> = 350/658) after ART start, 36%, 43% and 48% were virally suppressed, respectively (VL&lt;100 copies/ml). VS among children at 12 and 24 months was more likely if maternal VL was &lt;100 versus ≥100 copies/ml at 12 months (adjusted odds ratio [aOR] = 3.5; 95% CI 1.9−6.5) and 24 months (aOR = 6.1; 95% CI 2.8−13.1) after child ART start. Children with no/mild versus advanced/severe immunodeficiency at ART start were more likely to achieve VS at 12 months (aOR = 2.3; 95% CI 1.3−4.2) but not at 24 months. Eligible children with missing VL at 24 months (39%) were more likely to have gaps in care of &gt;6 months than those with VL≥100 or VL&lt;100 copies/ml (84% vs. 28% vs. 14%, respectively; <i>p</i>&lt;0.001).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Less than half of children on ART achieved VS, and children were more likely to achieve VS if their mothers were also virally suppressed. Significant efforts are needed to support mother-child dyads to achieve optimal VS.</p>\n </section>\n </div>","PeriodicalId":201,"journal":{"name":"Journal of the International AIDS Society","volume":"28 2","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782834/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the International AIDS Society","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jia2.26418","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Globally, children living with HIV continue to lag behind UNAIDS targets for viral suppression (VS). Because studies with linked mother-child data are limited, we describe VS and associated factors among young children in a setting with early infant HIV testing (at birth, age 10 weeks and 6 months) and early protease inhibitor-based first-line antiretroviral therapy (ART).

Methods

We analysed routinely collected mother-child data for children living with HIV born 2018–2022 in Western Cape province, South Africa (followed through mid-2023). We assessed associations between child and maternal viral load (VL) results at 12 and 24 months after child ART start using logistic regression, adjusted for child sex, birthyear, severity of child immunodeficiency at ART start, maternal age and timing of maternal HIV diagnosis.

Results

Among 2219 children living with HIV; 30% were diagnosed at birth (≤7 days), 41% before age 1 year (8−365 days) and 29% at age >1 year. Overall, 5% (n = 112/2219) of children died, a third of whom had not started ART; 90% of children (n = 1990) started ART, at median age 5 months (IQR 1–16). Median follow-up from ART start was 26 months (IQR 14–40). Among children with available VL at 12 months (n = 853/1582), 24 months (n = 614/1129) and 36 months (n = 350/658) after ART start, 36%, 43% and 48% were virally suppressed, respectively (VL<100 copies/ml). VS among children at 12 and 24 months was more likely if maternal VL was <100 versus ≥100 copies/ml at 12 months (adjusted odds ratio [aOR] = 3.5; 95% CI 1.9−6.5) and 24 months (aOR = 6.1; 95% CI 2.8−13.1) after child ART start. Children with no/mild versus advanced/severe immunodeficiency at ART start were more likely to achieve VS at 12 months (aOR = 2.3; 95% CI 1.3−4.2) but not at 24 months. Eligible children with missing VL at 24 months (39%) were more likely to have gaps in care of >6 months than those with VL≥100 or VL<100 copies/ml (84% vs. 28% vs. 14%, respectively; p<0.001).

Conclusions

Less than half of children on ART achieved VS, and children were more likely to achieve VS if their mothers were also virally suppressed. Significant efforts are needed to support mother-child dyads to achieve optimal VS.

Abstract Image

南非西开普省感染艾滋病毒的母子二人组:未检测到=未检测到?
导言:在全球范围内,感染艾滋病毒的儿童继续落后于联合国艾滋病规划署的病毒抑制目标。由于与母婴相关的研究数据有限,我们描述了在早期婴儿艾滋病毒检测(出生时、10周龄和6个月)和早期基于蛋白酶抑制剂的一线抗逆转录病毒治疗(ART)的环境中幼儿的VS和相关因素。方法:我们分析了南非西开普省2018-2022年出生的艾滋病毒感染儿童的常规母婴数据(随访至2023年中期)。我们使用logistic回归评估了儿童开始抗逆转录病毒治疗后12个月和24个月儿童和母亲病毒载量(VL)结果之间的相关性,并对儿童性别、出生年份、开始抗逆转录病毒治疗时儿童免疫缺陷严重程度、母亲年龄和母亲HIV诊断时间进行了调整。结果:2219例HIV感染儿童中;30%在出生时(≤7天)确诊,41%在1岁前(8-365天)确诊,29%在1 - 10岁确诊。总体而言,5% (n = 112/2219)的儿童死亡,其中三分之一未开始抗逆转录病毒治疗;90%的儿童(n = 1990)在中位年龄5个月(IQR 1-16)时开始抗逆转录病毒治疗。ART开始后的中位随访时间为26个月(IQR 14-40)。在抗逆转录病毒治疗开始后12个月(n = 853/1582)、24个月(n = 614/1129)和36个月(n = 350/658) VL可用的儿童中,病毒抑制率分别为36%、43%和48%(与VL≥100或VL6个月相比)。结论:接受抗逆转录病毒治疗的儿童中,只有不到一半的儿童实现VS,如果母亲也病毒抑制,儿童更有可能实现VS。为了达到最佳的VS,需要大量的努力来支持母子二人组。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of the International AIDS Society
Journal of the International AIDS Society IMMUNOLOGY-INFECTIOUS DISEASES
CiteScore
8.60
自引率
10.00%
发文量
186
审稿时长
>12 weeks
期刊介绍: The Journal of the International AIDS Society (JIAS) is a peer-reviewed and Open Access journal for the generation and dissemination of evidence from a wide range of disciplines: basic and biomedical sciences; behavioural sciences; epidemiology; clinical sciences; health economics and health policy; operations research and implementation sciences; and social sciences and humanities. Submission of HIV research carried out in low- and middle-income countries is strongly encouraged.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信